AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
147 hedge funds and large institutions have $1.11B invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 25 closing their positions.
1,948% more call options, than puts
Call options by funds: $191M | Put options by funds: $9.33M
24% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 49
12% more capital invested
Capital invested by funds: $987M → $1.11B (+$120M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2% less funds holding
Funds holding: 150 → 147 (-3)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$30.6M |
| 2 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
+$17.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.7M |
| 4 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$13.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$21.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20.6M |
| 3 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$13.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$11M |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$10.9M |
AUXL Hedge Fund Activity: Q4 2013 in Review
147 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2013, worth a combined $1.11B — up 12% from $987M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of AUXL and 22 opened new positions — a net loss of 3 holders — while 49 trimmed existing stakes and 61 added.
The largest buyer was Deerfield Management, adding an estimated $30.6M. The largest seller was Artal Group, cutting an estimated $21.4M.
- 147 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2013, down from 150 in Q3 2013.
- Funds reported $1.11B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2013, up 12% quarter-over-quarter.
- 22 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2013 and 25 closed out, a net change of -3 holders.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2013 was Deerfield Management, an estimated $30.6M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2013 was Artal Group, an estimated $21.4M sold.
Based on aggregated 13F filings for Q4 2013.